AstraZeneca PLC ADR
Stock Chart, Company Information, and Scan Results
$77.69(as of Sep 17, 9:48 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
AstraZeneca PLC ADR Company Information, Fundamentals, and Technical Indicators
Stock Price$77.69
Ticker SymbolAZN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees94,300
CountyUSA
Market Cap$248,209.9M
EBIDTA19,128.0M
P/E Ratio29.15
Forward P/E Ratio15.46
Earnings per Share2.65
Profit Margin16.95%
RSI43.12
Shares Outstanding3,100.5M
ATR1.23
52-Week High82.41
Volume3,408,409
52-Week Low60.83
Book Value44,810.0M
P/B Ratio5.40
Upper Keltner83.11
P/S Ratio4.28
Lower Keltner77.56
Debt-to-Equity Ratio83.11
Next Earnings Date11/06/2025
Cash Surplus-26,478.0M
Next Ex-Dividend DateUnknown
AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.
AstraZeneca PLC ADR In Our Stock Scanner
As of Sep 17, 2025
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.